
Thermo Fisher Scientific Inc.
TMO 515.60 (-0.16%) 0.84
Health Care
Life Sciences Tools and Services
Quality Checklist 6/8
5Y Shares Out Change < 0%
Debt/Equity < 1
Current Ratio > 1
Quick Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
ROIC > 10%
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $193.72(B)
EV: $226.63(B)
Total Equity: $53.54(B)
Earnings date: Apr-22-2026
P/E: 29.00
Forward P/E: 21.01
P/FCF: 30.80
P/S: 4.36
P/B: 3.63
EPS: $17.8
EPS (fwd): $24.5
FCF/share: $16.7
Revenue/share: $118.2
Book value/share: $142.1
ROIC: 7.7%
ROA: 6.5%
ROE: 13.1%
Debt/Equity: 0.74
Current Ratio: 1.90
Gross margin: 41.7%
Operating margin: 18.4%
Net margin: 15.0%
Dividend/share: $1.7
Div. yield: 0.33%
Growth Estimates
Revenue
CAGR: 5.2%FY+1$46.82(B)
FY+2(+5.3%)$49.28(B)
FY+3(+6.4%)$52.45(B)
FY+4(+4.1%)$54.62(B)
FY+5(+4.8%)$57.24(B)
Net Income
CAGR: 8.7%FY+1$9.18(B)
FY+2(+8.5%)$9.96(B)
FY+3(+8.8%)$10.84(B)
FY+4(+10.0%)$11.93(B)
FY+5(+7.4%)$12.81(B)
EPS
CAGR: 11.4%FY+1$24.54
FY+2(+9.8%)$26.94
FY+3(+10.3%)$29.72
FY+4(+11.5%)$33.13
FY+5(+14.1%)$37.81
FCF per share
CAGR: 16.1%FY+1$18.96
FY+2(+26.2%)$23.92
FY+3(+6.8%)$25.54
